Harris Matthew John, Cossburn Mark Daniel, Pengas George
Wessex Neurological Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK
Neurology Department, Poole Hospital NHS Foundation Trust, Poole, UK.
Pract Neurol. 2019 Jun;19(3):246-249. doi: 10.1136/practneurol-2018-002133. Epub 2019 Jan 30.
A 52-year-old man experienced a relapse of neurosarcoidosis, characterised by obstructive hydrocephalus and multiple posterior circulation infarcts. He was taking methotrexate, but his prednisolone was being weaned because of adverse effects. Stroke is rare in neurosarcoidosis and typically relates to granulomatous inflammation with a predilection for the perforator arteries. Sarcoidosis generally responds well to corticosteroids; however, patients with leptomeningeal involvement usually require additional immunosuppression as relapses can occur on weaning of corticosteroids. It is worth considering tumour necrosis factor-α antagonists for cases that progress despite first-line therapy.
一名52岁男性出现神经结节病复发,表现为梗阻性脑积水和多发后循环梗死。他正在服用甲氨蝶呤,但由于不良反应,其泼尼松龙正在逐渐减量。中风在神经结节病中罕见,通常与肉芽肿性炎症有关,且好发于穿支动脉。结节病一般对皮质类固醇反应良好;然而,软脑膜受累的患者通常需要额外的免疫抑制治疗,因为在皮质类固醇逐渐减量时可能会复发。对于一线治疗无效的进展性病例,值得考虑使用肿瘤坏死因子-α拮抗剂。